Guwahati: In a recent development, the first batch of the Sputnik V vaccine against the novel Coronavirus, developed by Russia's Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), has been released into civil circulation.
After the development came to light, the Russian health ministry has stated that regional deliveries are planned in the nearest future.
"The first batch of the 'Gam-COVID-Vac' [Sputnik V] vaccine for the prevention of the new coronavirus infection, developed by the Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia, has passed the necessary quality tests in the laboratories of Roszdravnadzor [medical device regulator] and has been released into civil circulation," the Russian health ministry informed.
Earlier on August 11 , the Russian health ministry enrolled the first vaccine against Covid-19, named Sputnik V.
On Sunday, Moscow Mayor Sergey Sobyanin expressed his hope that the majority of the Russian capital's residents would be vaccinated against the dreaded coronavirus within the next few months.
As per the health ministry, delivery of the first batches of the Russian vaccine to the country's regions is planned in the nearest future.
According to preliminary results published in The Lancet journal, Russia's covid-19 vaccine, Sputnik V, seems to be safe without any serious adverse effects and has developed long-term antibody response in humans during clinical trials.